NCT02245269View on ClinicalTrials.gov

Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2003

Conditions
Healthy
Interventions
DRUG

Tipranavir

DRUG

Ritonavir

DRUG

Atorvastatin

DRUG

Maalox

Aluminum Hydroxide; Magnesium Hydroxide; Simethicone

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02245269 - Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers | Biotech Hunter | Biotech Hunter